Skip to main content
. 2013 Dec 3;2013:898719. doi: 10.1155/2013/898719

Table 1.

Classification of patients with T1 invasive melanoma according to the 2001 and 2009 AJCC staging and classification system (N = 106).

Melanoma categories 2001 AJCC, 6th edition 2009 AJCC, 7th edition Reclassified T1 melanomas according to 2009 AJCC staging Median BT in mm (range)
Clark level Mitosis Ulceration T1a T1b T1a T1b
II 31 0 31 0 No 0.30 (0.12–1.0)
II + 3 0 0 3 Yes 0.70 (0.44–0.80)
II + 0 1 0 1 No 0.64 (0.64–0.64)
II + + 0 0 0 0 No
III 14 0 14 0 No 0.55 (0.38–0.85)
III + 12 0 0 12 Yes 0.79 (0.35–1.0)
III + 0 0 0 0 No
III + + 0 3 0 3 No 0.90 (0.65–0.94)
IV 0 16 16 0 Yes 0.55 (0.32–0.98)
IV* + 0 26 0 26 No 0.70 (0.44–0.98)
IV + 0 0 0 0 No
IV + + 0 0 0 0 No

Total 60 46 61 45 31 0.60 (0.12–1.0)

Reclassified T1a and T1b cohorts are listed in bold. Median BT of 0.30 mm was significantly lower compared to BT in other categories: (P < 0.01). Mitosis “+”: 1 or more dermal tumor mitosis/mm2; mitosis “−”: <1 or 0 dermal tumor mitosis/mm2; ulceration “+”: histological absence of epidermis with accompanying inflammatory crust; ulceration “−”: histologically intact epidermis; BT: Breslow thickness; *category with positive sentinel lymph node biopsy (SLNB).